Further characterization of Notch/HEY1 target gene expression and NCOA2-related nuclear receptor target genes in mesenchymal chondrosarcoma may provide insight into avenues for treatment with targeted therapies. The gene discussed is HEY1; the disease is chondrosarcoma.